📰 Systemic Sclerosis News
Page 5 - Systemic Sclerosis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Systemic Sclerosis. Real-time updates on events, politics, business and more.
May 2, 2023
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release the first quarter...
April 18, 2023
INSIDE INFORMATION Patent covers the therapeutic use of a new composite formulation of anti-inflammatory compounds with unique advantages BioSenic’s new formulation lowers the dosage of... | April 18, 2023
April 3, 2023
/PRNewswire/ -- Aisa Pharma, Inc. a private, clinical-stage biopharmaceutical company, today announced it will present data on its clinical drug candidate,...
April 2, 2023
INSIDE INFORMATION Mont-Saint-Guibert, Belgium, March 31, 2023, 7am CET - BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases
March 31, 2023
BIOSENIC (Euronext Brussels and Paris: BIOS), the clinical stage company specializing in severe autoimmune/inflammatory diseases and cellular repair, provides today a financial update and publishes its financial calendar for the year 2023. Financial Update As a result of cost management efforts made and payments ...
March 30, 2023
INSIDE INFORMATION Combination of ATO with copper salts will allow BioSenic to work towards reducing the dosage of ATO in future trials overall and maintain efficacy Mont-Saint-Guibert,... | March 30, 2023
March 7, 2023
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company today announced full year 2022 financial results and...
March 4, 2023
Despite ILD being a leading cause of death in RA patients, there are no clinical guidelines for monitoring this lung condition in this population, experts say.
February 28, 2023
/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceuticals company, announced today that it will release its annual 2022...
February 14, 2023
Mont-Saint-Guibert, Belgium, February 14, 2023, 5:45 pm CET – BioSenic , the clinical stage company specializing in serious autoimmune / inflammatory diseases and cell repair, today... | February 14, 2023